AngioDynamics (ANGO) Earnings Analysis

AngioDynamics (ANGO) next reports earnings on 2026-10-01, consensus EPS -0.09 USD. Last quarter (2026-07-14) it beat with EPS -0.07 USD vs -0.11 USD est (+36.4%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E -15.70.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ANGO next report earnings?

Next earnings date2026-10-01
Consensus EPS estimate-0.09 USD
Revenue estimate0.08B

ANGO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-14-0.07 USD-0.11 USD+36.4%Beat
2026-04-02-0.07 USD-0.11 USD+36.4%Beat
2026-01-06-0.15 USD-0.1 USD-50%Miss
2025-10-02-0.1 USD-0.14 USD+28.6%Beat
2025-07-15-0.03 USD-0.13 USD+76.9%Beat
2025-04-020.03 USD-0.13 USD+123.1%Beat
2025-01-08-0.04 USD-0.11 USD+63.6%Beat
2024-10-03-0.11 USD-0.15 USD+26.7%Beat

Beat rate: 7/8 (88%) over reported quarters with consensus data.

ANGO valuation and analyst view

Trailing P/E-15.70
Trailing EPS-0.8848 USD
Price / book3.36
Dividend yield0.00%
Market cap0.58B
Analyst consensusHold (5 buy / 6 hold / 0 sell)
Avg price target19.5 USD

Related research pages

Frequently asked questions

When is AngioDynamics (ANGO)'s next earnings date?

AngioDynamics is next scheduled to report on 2026-10-01, with a consensus EPS estimate of -0.09 USD and revenue estimate of 0.08B.

Did ANGO beat earnings last quarter?

In its 2026-07-14 report, ANGO posted EPS of -0.07 USD versus a -0.11 USD estimate — a beat of 36.4%.

What is ANGO's earnings track record?

Over the last 8 reported quarters with consensus data, ANGO beat estimates 7 times (88%).

What is ANGO's current P/E ratio and EPS?

ANGO trades at a trailing P/E of -15.70 on trailing EPS of -0.8847950681500747 USD.

What do analysts rate ANGO?

Analyst consensus is "Hold" across 11 ratings (0 strong buy, 5 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 19.5 USD.